Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

6.790 -0.280 (-3.96%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Maravai LifeSciences Appoints Trey Martin to Board of Directors

July 29, 2024

Maravai announces the appointment of CEO Trey Martin to its Board of Directors, highlighting his leadership, commitment to innovation, and industry experience

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024

July 10, 2024

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report

July 02, 2024

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Where Maravai LifeSciences Stands With Analysts ↗

May 09, 2024

Via Benzinga

Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 29, 2024

Via Benzinga

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center

May 13, 2024

From TriLink BioTechnologies

Via Business Wire

Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule

May 09, 2024

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript ↗

May 09, 2024

MRVI earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

MRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

MRVI stock results show that Maravai LifeSciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Maravai LifeSciences Reports First Quarter 2024 Financial Results

May 08, 2024

Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

April 30, 2024

From TriLink BioTechnologies

Via Business Wire

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

April 18, 2024

From TriLink BioTechnologies

Via Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024

April 10, 2024

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday ↗

April 09, 2024

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.

Via Benzinga

Topics Stocks

Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report

April 04, 2024

Via AB Newswire

Topics Regulatory Compliance

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

March 12, 2024

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA

March 08, 2024

Via AB Newswire

Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS

February 28, 2024

Via AB Newswire

Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI

February 26, 2024

Via AB Newswire

Nasdaq Edges Lower; AXT Shares Surge After Q4 Results ↗

February 23, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 0.2% on Friday. The Dow traded up 0.23% to 39,158.52 while the NASDAQ fell 0.19% to 16,011.27. The S&P 500...

Via Benzinga

Topics Stocks

Small-Cap Maravai LifeSciences' Q4 Outperforms Expectations, Analyst shows Optimism Around 2024 Guidance ↗

February 23, 2024

Maravai LifeSciences impresses with Q4 2023 revenue of $74.1 million, surpassing estimates. CEO Trey Martin highlights strong execution, cost reductions, and a 28% adjusted EBITDA margin. 2024 revenue...

Via Benzinga

Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 23, 2024

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 23, 2024

Via Benzinga

Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher ↗

February 23, 2024

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index jumping more than 100 points on Friday. The Dow traded up 0.36% to 39,209.32 while the NASDAQ rose 0.01% to 16,042.80....

Via Benzinga

Topics Stocks

Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday ↗

February 23, 2024

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.

Via Benzinga

Topics Stocks

Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings ↗

February 23, 2024

U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.

Via Benzinga

Topics Stocks

Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket ↗

February 23, 2024

Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 23, 2024

Via Benzinga

Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate Cuts ↗

February 23, 2024

After the exuberance seen on Thursday, investors may assess whether it was an irrational one, and futures trading on Friday reflects edginess.

Via Benzinga

Topics Stocks

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.